Improvement in Pain and Function Following a Physiotherapy Program in Older Adults With Knee Osteoarthritis

December 11, 2017 updated by: Josue Fernandez Carnero, Universidad Rey Juan Carlos

Improvement in Pain and Function Following a Therapeutic Exercise Program and Dry Needling in Older Adults With Knee Osteoarthritis: A Randomized Double-blind Multicenter Controlled Clinical Trial

This study evaluates the combination of a therapeutic exercise program and dry needling in the treatment of knee osteoarthritis in older adults. Half of participants will receive therapeutic exercise program and dry needling in combination, while the other half will receive the same therapeutic exercise program and sham dry needling.

Study Overview

Detailed Description

Therapeutic exercise and dry needling each relieve pain and improve function, but they are different treatment tools.

Therapeutic exercise takes a multitude of forms and results in numerous systemic and local effects, some of which have been investigate among people with knee osteoarthritis. Therapeutic exercise covers a range of targeted physical activities that directly aim to improve muscle strength, neuromotor control, joint range of motion and aerobic fitness. One of the main aims of this therapeutic approach is to improve muscle strength, given that weakness is common in knee osteoarthritis. Enhanced strength of the lower limb may lessen internal knee forces, reduce pain and improve physical function.

Primary knee osteoarthritis provokes pain and disfunction is thought mediated by joint damage and changes in joint homeostasis. Recently, investigations focused in impaired neuromuscular system as a contribution to the above mentioned symptoms in the knee osteoarthritis syndrome explore the use of dry needling. Dry needling is a therapeutic approach for decreasing pain and improve function with high recommended evidence (grade A) effectiveness for upper-quarter myofascial pain, but poorly understood in knee osteoarthritis patients.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Alcorcón, Madrid, Spain, 28922
        • Universidad Rey Juan Carlos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

62 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants aged 62 years and older.
  • Unilateral or bilateral disfunction and/or knee pain.
  • Primary knee ostearthritis fulfilling the American College of Rheumatology criteria for clinical and radiographic diagnostic.
  • At least 1 pain point elicited by palpation ipsilateral to the painful knee situated in a taut band of a skeletal muscle of the lower limbs, which usually have referred pain.

Exclusion Criteria:

  • Prior diagnoses or prescriptions in the medical record for myopathy or lumbo-sacral neuropathy.
  • Previous knee or hip joint replacement surgery of the affected joint.
  • Any other surgical procedure of the lower limbs in the previous 6 months.
  • Rheumatoid arthritis.
  • Initiation of opioid analgesia or cortico-steroid or analgesic injection intervention for hip or knee pain within the previous 30 days.
  • Alcohol or drugs consumption.
  • Uncontrolled hypertension or moderate to high risk for cardiac complications during exercise.
  • Conservative or invasive physical therapy (previous 6 months or during follow-up).
  • Taking antiaggregant or anticoagulant medications.
  • Physical impairments unrelated to the hip or knee preventing safe participation in exercise, walking or stationary cycling, such as: vision problems that affect mobility, body weight greater than 155 kg, neurogenic disorder, primary or significantly limiting back pain, advanced osteoporosis, or inability to walk 10 metres without an assistive device.
  • Inability to comprehend and complete study assessments or comply with study instructions.
  • Stated inability to attend or complete the proposed course of intervention and follow-up schedule.
  • Fibromyalgia syndrome or other altered affective/cognitive modulation processes of pain perception. .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise and dry needling

24 therapeutic exercise sessions (twice a week) of a land-based therapeutic exercise program consisting of aerobic exercise (20-25 min warm-up), lower limbs muscle strengthening (20-25 min) and lower limbs muscles stretching (10-15 min).

6 dry needling sessions (once a week) at all the pain points of the involved symptomatic lower limb/s using Hong's fast-in and fast-out technique with multiple rapid needle insertion.

20-25 minutes aerobic exercise, 20-25 minutes strength exercise and 10-15 minutes stretch exercise.
Dry needling needle AGUPUNT®
Active Comparator: Exercise and sham dry needling

24 therapeutic exercise sessions (twice a week) of a land-based therapeutic exercise program consisting of aerobic exercise (20-25 min warm-up), lower limbs muscle strengthening (20-25 min) and lower limbs muscles stretching (10-15 min).

6 sham dry needling sessions (once a week) at all the pain points of the involved symptomatic lower limb/s using a park sham device consists of a base with a hole in the centre and sticky tape on the bottom. From the top of the base extends a double tube, continuing the central hole in the base.

20-25 minutes aerobic exercise, 20-25 minutes strength exercise and 10-15 minutes stretch exercise.
Sham dry needling DONGBANG-ACUPRIME®

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Western Ontario and McMaster Osteoarthritis Index (WOMAC) change assessment.
Time Frame: Base line, through study completion (3 months); and 3, 6 and 12 months follow-up
The disease-specific questionnaire WOMAC is the most widely used instrument created and validated to evaluate both the symptomatology and function on osteoarthritis of the hip or knee.
Base line, through study completion (3 months); and 3, 6 and 12 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: Base line, through study completion (3 months); ; and 3, 6 and 12 months follow-up
Pain intensity will be assessed using a NPRS of 11 points (from 0, no pain, to 10, maximum pain). The patient determined their subjective pain intensity of the painful knee by pointing with 1 of their fingers to mark the level of pain on the scale. .
Base line, through study completion (3 months); ; and 3, 6 and 12 months follow-up
Barthel Index
Time Frame: Base line, through study completion (3 months); and 3, 6 and 12 months follow-up
The Barthel Index is considered to be the best of the activities of daily living measurement scales. The modified scoring of the Barthel Index by Shah achieved greater sensitivity and improved reliability than the original version, without causing additional difficulty or affecting the implementation time.
Base line, through study completion (3 months); and 3, 6 and 12 months follow-up
The Timed Up & Go Test
Time Frame: Base line, through study completion (3 months); and 3, 6 and 12 months follow-up
The patient is asked to perform the rise from a standard arm chair, walk to a line on the floor 3 meters away, turn, return, return and sit down again. The score given is the time taken in seconds to complete the test.
Base line, through study completion (3 months); and 3, 6 and 12 months follow-up
Mini-Mental State Examination (MMSE)
Time Frame: Base line and 12 months follow-up
It's a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment and to screen for dementia.
Base line and 12 months follow-up
EuroQol-5
Time Frame: Base line, through study completion (3 months); and 3, 6 and 12 months follow-up
It provides a simple descriptive profile and a single index value for health status through rating of 5 items.
Base line, through study completion (3 months); and 3, 6 and 12 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total number of falls change assessment.
Time Frame: At Baseline and 1 year follow-up.
Total number of falls at 1 year follow-up, and to compare with number of falls at one year before the participation on the study.
At Baseline and 1 year follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eleuterio Atanasio Sánchez Romero, PT, MSc, Universidad Rey Juan Carlos

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2016

Primary Completion (Actual)

June 16, 2016

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

January 4, 2016

First Submitted That Met QC Criteria

February 28, 2016

First Posted (Estimate)

March 3, 2016

Study Record Updates

Last Update Posted (Actual)

December 12, 2017

Last Update Submitted That Met QC Criteria

December 11, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe